Return-path: <gspier@unitaqbio.com>
Envelope-to: info@riw-sv.com
Delivery-date: Tue, 23 Oct 2012 16:19:10 -0500
Received: from smtpout04-01.prod.mesa1.secureserver.net ([64.202.165.196]:48762 helo=smtpout04.prod.mesa1.secureserver.net)
	by sprinter.websitewelcome.com with smtp (Exim 4.80)
	(envelope-from <gspier@unitaqbio.com>)
	id 1TQlsU-0000i0-70
	for info@riw-sv.com; Tue, 23 Oct 2012 16:19:10 -0500
Received: (qmail 11591 invoked from network); 23 Oct 2012 21:19:09 -0000
Received: from unknown (66.201.49.121)
  by smtpout04.prod.mesa1.secureserver.net (64.202.165.196) with ESMTP; 23 Oct 2012 21:19:09 -0000
Reply-To: <gspier@unitaqbio.com>
From: "Eugene Spier" <gspier@unitaqbio.com>
To: <info@riw-sv.com>
Subject: Registration for Russian innovation week request
Date: Tue, 23 Oct 2012 14:18:51 -0700
Organization: UniTaq Bio
Message-ID: <024001cdb164$007adbb0$01709310$@com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_0241_01CDB129.541C03B0"
X-Mailer: Microsoft Office Outlook 12.0
Content-Language: en-us
Thread-Index: Ac2xY///jem7XkkRR8+XJlOTWR3Wvw==

This is a multi-part message in MIME format.

------=_NextPart_000_0241_01CDB129.541C03B0
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

Hi -

 

Can you please register me for the conference.   I hope this is still
possible, may be you have cancellations.

 

Eugene (Gene) Spier, Ph.D.

President and Founder, UniTaq Bio

1455 Adams Dr, Suite #1289

Menlo Park,  CA   94025

gspier@unitaqbio.com   www.unitaqbio.com

650-533-8723;  650-949-1188 (FAX)

 

UniTaq Bio is molecular diagnostics biotech early stage start-up.  We
develop molecular diagnostics tests.  Our first diagnostic application is an
inexpensive and simple test for drug resistant tuberculosis (multi/extreme
drug resistant MDR/XDR MTB).  MDR/XDR MTB detection that is important
medical condition in Russia.  We collaborate on this project with
tuberculosis research lab at Stanford (Prof. Schoolnik) and will be looking
for clinical testing place.   Russia would be an ideal place for this work
and we can establish a partnership.  

My background <http://www.linkedin.com/in/genespier> :  I emigrated to the
US from the former Soviet Union in 1989; lead TaqMan assay R&D at Life
technologies for 15 years and started UniTaq Bio in 2011.

 

Company Background: UniTaq Bio (Menlo Park, CA) has developed a novel closed
tube multiplex qPCR technology to detect nucleic acids targets. Most tests
today require a single tube per test. With UniTaq Bio's technology, most
tests would require a single qPCR well. This lowers the cost of testing,
simplifies the lab workflow, and speeds up assay development. The assays can
be used on any qPCR or capillary electrophoresis instrument. UniTaq has
established a collaboration to develop multiplexed closed tube assay for MTB
(tuberculosis) drug resistance: detecting 24 mutations that cause resistance
to 3 drugs in a single well. Our technology multiplexes tagged
target-specific and universal labeled primers that detect these tags. All
target mutations that cause resistance to a drug use identical tags, so that
if any target mutation is present, the universal primers will generate
signal indicating the resistance to this drug.

 

Thank you !

Sincerely,  Gene

 

 

 

 


------=_NextPart_000_0241_01CDB129.541C03B0
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:x=3D"urn:schemas-microsoft-com:office:excel" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dus-ascii"><meta name=3DGenerator content=3D"Microsoft Word 12 =
(filtered medium)"><style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:purple;
	text-decoration:underline;}
span.EmailStyle17
	{mso-style-type:personal-compose;
	font-family:"Calibri","sans-serif";
	color:windowtext;}
.MsoChpDefault
	{mso-style-type:export-only;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]--></head><body lang=3DEN-US link=3Dblue =
vlink=3Dpurple><div class=3DWordSection1><p class=3DMsoNormal>Hi =
&#8211;<o:p></o:p></p><p class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal>Can you please register me for the =
conference.&nbsp;&nbsp; I hope this is still possible, may be you have =
cancellations&#8230;<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal>Eugene =
(Gene) Spier, Ph.D.<o:p></o:p></p><p class=3DMsoNormal>President and =
Founder, UniTaq Bio<o:p></o:p></p><p class=3DMsoNormal>1455 Adams Dr, =
Suite #1289<o:p></o:p></p><p class=3DMsoNormal>Menlo Park,&nbsp; =
CA&nbsp;&nbsp; 94025<o:p></o:p></p><p =
class=3DMsoNormal>gspier@unitaqbio.com&nbsp;&nbsp; =
www.unitaqbio.com<o:p></o:p></p><p class=3DMsoNormal>650-533-8723;&nbsp; =
650-949-1188 (FAX)<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p class=3DMsoNormal><span =
style=3D'color:#1F497D'>UniTaq Bio is molecular diagnostics biotech =
early stage start-up.&nbsp; We develop molecular diagnostics =
tests.&nbsp; Our first diagnostic application is an inexpensive and =
simple test for drug resistant tuberculosis (multi/extreme drug =
resistant MDR/XDR MTB).&nbsp; MDR/XDR MTB detection that is important =
medical condition in Russia.&nbsp; We collaborate on this project with =
tuberculosis research lab at Stanford (Prof. Schoolnik) and will be =
looking for clinical testing place.&nbsp; &nbsp;Russia would be an ideal =
place for this work and we can establish a partnership.&nbsp; =
<o:p></o:p></span></p><p class=3DMsoNormal><span =
style=3D'color:#1F497D'><a =
href=3D"http://www.linkedin.com/in/genespier">My background</a>:&nbsp; I =
emigrated to the US from the former Soviet Union in 1989; lead TaqMan =
assay R&amp;D at Life technologies for 15 years and started UniTaq Bio =
in 2011.<o:p></o:p></span></p><p class=3DMsoNormal><b><span =
style=3D'color:#1F497D'><o:p>&nbsp;</o:p></span></b></p><p =
class=3DMsoNormal><b><span style=3D'color:#1F497D'>Company =
Background:</span></b><span style=3D'color:#1F497D'> UniTaq Bio (Menlo =
Park, CA) has developed a novel closed tube multiplex qPCR technology to =
detect nucleic acids targets. Most tests today require a single tube per =
test. With UniTaq Bio&#8217;s technology, most tests would require a =
single qPCR well. This lowers the cost of testing, simplifies the lab =
workflow, and speeds up assay development. The assays can be used on any =
qPCR or capillary electrophoresis instrument. UniTaq has established a =
collaboration to develop multiplexed closed tube assay for MTB =
(tuberculosis) drug resistance: detecting 24 mutations that cause =
resistance to 3 drugs in a single well. Our technology multiplexes =
tagged target-specific and <i>universal labeled primers </i>that detect =
these tags. All target mutations that cause resistance to a drug use =
identical tags, so that if <i>any</i> target mutation is present, the =
universal primers will generate signal indicating the resistance to this =
drug.<o:p></o:p></span></p><p class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal>Thank you !<o:p></o:p></p><p =
class=3DMsoNormal>Sincerely,&nbsp; Gene<o:p></o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p><p =
class=3DMsoNormal><o:p>&nbsp;</o:p></p></div></body></html>
------=_NextPart_000_0241_01CDB129.541C03B0--

